STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
41 hedge funds and large institutions have $147M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
Holders
41
Holding in Top 10
1
Calls
$5.3M
Puts
$67K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$1.61M | |
| 3 | +$894K | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$539K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$406K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$624K | |
| 3 | -$347K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$318K |
| 5 |
JPMorgan Chase & Co
New York
|
-$195K |